USFDA issues EIR for Lupin Aurangabad facility Ruchika Sharma24 April 2024 11:46 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
Eli Lilly buys new injectable medicine manufacturing facility from Nexus Pharma Ruchika Sharma23 April 2024 12:30 PM ISTIndianapolis: Eli Lilly and Company and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing...
Sandoz confirms European Commission nod of Pyzchiva Ruchika Sharma23 April 2024 11:54 AM ISTBasel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab) developed...
Zydus Lifesciences launches Mirabegron ER Tablets in US for overactive bladder treatment Ruchika Sharma22 April 2024 2:47 PM ISTMirabegron is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency.
Zydus Lifesciences arm gets marketing nod for Nulibry from UK MHRA for MoCD Type A Ruchika Sharma22 April 2024 2:08 PM ISTAhmedabad: Zydus Lifesciences Ltd. has announced that its wholly-owned subsidiary Sentynl Therapeutics, Inc., has received marketing...
Lupin unveils Mirabegron ER tablets in US Ruchika Sharma22 April 2024 12:09 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after...
Merck unveils all-in-one genetic stability assay to accelerate biosafety testing Ruchika Sharma21 April 2024 5:37 PM ISTGermany: Merck, a science and technology company, has launched the all-in-one, validated genetic stability assay of its kind. The Aptegra CHO...
Novartis Gets CDSCO Panel Nod to Study anti-cancer drug Ribociclib Dr. Divya Colin21 April 2024 5:30 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Eli Lilly's protocol amendment proposal for Adjuvant Imlunestrant vs Standard Adjuvant study Dr. Divya Colin21 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
Novo Nordisk Gets CDSCO Panel Nod to Study new medicine NNC0519-0130 Dr. Divya Colin21 April 2024 5:00 PM ISTNew Delhi: The drug major Novo Nordisk has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease Ruchika Sharma21 April 2024 10:00 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC)...
